Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes
Lipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the...
Trending menu:
-
![Digital Research]()
Scientist.com and Austrade to expand digital research marketplace in Australia
-
![]()
Elligo Health unveils new clinical trials technology
-
![]()
Olumiant (baricitinib) for the Treatment of Moderate-to-Severe Rheumatoid Arthritis
-
![]()
Cabometyx (cabozantinib) for Treatment of Patients with Advanced Renal Cell Carcinoma
-
![]()
Keytruda (pembrolizumab) for the Treatment of Metastatic Melanoma
-
![]()
Tremfya (guselkumab) for the Treatment of Plaque Psoriasis
Most Read
- Celltrion implements Veeva Vault eTMF to improve visibility into clinical trial activities
- Parexel launches integrated FPS model to drive delivery of clinical research partnerships
- Medable unveils telemedicine solution only for clinical trials
- Broader inclusion criteria to double eligible cancer patients for clinical trials, finds study
- Find out how pharma is fighting respiratory illnesses in the latest Pharma Technology Focus
Company A-Z
Latest Content
IQVIA enables direct patient access to trial information
IQVIA has launched a new web-based solution to offer patients a direct access point for clinical trial information following their enrolment.
C-Path, NORD launch FDA-funded rare disease data and analytics platform
Independent non-profit organisation Critical Path Institute (C-Path) and advocacy organisation National Organisation for Rare Disorders (NORD) are set to formally launch development of a new rare disease data and analytics platform.
Symphogen selects TransPerfect’s TI GlobalLearn learning management system
Privately owned biotech company Symphogen has chosen TransPerfect Life Sciences’ Trial Interactive (TI) GlobalLearn learning management system to simplify learning in clinical trials.
HCL Technologies, Oracle partner to scale mHealth in clinical trials
Global technology company HCL Technologies and Oracle Health Sciences have partnered to scale up mHealth in clinical trials.
Phesi launches AI-powered clinical trial investigator tool ClinSite
Phesi has launched ClinSite, a self-service, artificial intelligence (AI)-powered tool which enables biopharmaceutical companies to search for top-performing investigator sites for clinical trials in all therapeutic areas.
Cincinnati Children’s new AI system reduces patient screening time
Researchers at Cincinnati Children’s Hospital Medical Center in the US have designed and tested a new computerised solution which uses artificial intelligence (AI) to effectively identify eligible participants from electronic health records (EHRs).
ClinOne to offer free patient recruitment to sponsors in 2020
ClinOne, a provider of technologies for clinical trials, is set to launch a direct-to-patient recruitment platform in the first quarter of next year.
Cambridge Cognition enters new partnership to further validate NeuroVocalix platform
Cambridge Cognition, a provider of cognitive assessment software for clinical trials, has announced its second commercial partnership with a pharmaceutical company, for its NeuroVocalix platform.
Optimal JIT, CTCA to speed-up patient enrolment in cancer trials
Global contract research organisation PPD’s Accelerated Enrollment Solutions (AES) business unit Optimal just-in-time (JIT) has entered into a partnership with Cancer Treatment Centers of America (CTCA).
Boston University to use Seqster Research Portal for Alzheimer’s study
Seqster and Boston University have expanded their partnership, pursuant to which, the latter will use Seqster’s Research Portal (SRP) solution that enables study participants to instantly collect and share medical records and device data with researchers.
Latest News
Close
Close
Close
Go Top
